Consultation Document - points to consider on the evaluation of new anti-fungal agents for invasive fungal infections. Issued by the Committee for Proprietary Medicinal Products (CPMP); the European Medicines Agency. This draft document is intended for clinicians and feedback is requested. (July 02)